TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 26561628

Group type: EXPERIMENTAL
Intervention: High-monounsaturated fatty acid (HMUFA) diet
Number of subjects: 472

Group type: EXPERIMENTAL
Intervention: Low-fat, high-complex carbohydrate (LFHCC) diet supplemented with long-chain n-3 polyunsaturated fatty acids (1.2 g/d)
Number of subjects: 472

Group type: COMPARATOR
Intervention: Low-fat, high-complex carbohydrate (LFHCC) diet (control)
Number of subjects: 472

Group type: EXPERIMENTAL
Intervention: High-saturated fatty acid (HSFA) diet
Number of subjects: 472
Study: 23832463

Group type: EXPERIMENTAL
Intervention: 4000 UI/week i.v. of epoetin alfa, beta or any other epoetin in equivalent doses
Number of subjects: 900

Group type: COMPARATOR
Intervention: 18000 UI/week i.v. of epoetin alfa, beta or any other epoetin in equivalent doses
Number of subjects: 900
Study: 21742107

Group type: EXPERIMENTAL
Intervention: Higher mean BMI during follow-up years (between-person BMI)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Decreasing BMI (within-person BMI change)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Decreasing BMI
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Weight gain
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Weight reduction
Number of subjects: 0
Study: 19349313

Group type: EXPERIMENTAL
Intervention: Single-dose (21- or 35-mg) nicotine patch
Number of subjects: 19

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study: 16912031

Group type: EXPERIMENTAL
Intervention: Fluoxetine
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Citalopram
Number of subjects: 37
Study: 14872417

Group type: EXPERIMENTAL
Intervention: Recombinant factor VIIa (rFVIIa)
Number of subjects: 0
Study: 11423598

Group type: EXPERIMENTAL
Intervention: Double gloving
Number of subjects: 66

Group type: COMPARATOR
Intervention: Single gloving
Number of subjects: 66
Study: 9413736

Group type: EXPERIMENTAL
Intervention: buspirone (45 mg)
Number of subjects: 0

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 0
Study: 7741805

Group type: EXPERIMENTAL
Intervention: High-dose vecuronium (0.3 mg kg ‐1)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Suxamethonium (1.0 mg kg ‐1)
Number of subjects: 50
Study: 3948472

Group type: EXPERIMENTAL
Intervention: Cholestyramine 2 hours before HCTZ
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Cholestyramine 2 hours after HCTZ
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control (no cholestyramine)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Single dose of cholestyramine 4 hours after HCTZ
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Multiple doses of cholestyramine (-24, -12, and +4 hours after HCTZ)
Number of subjects: 10
Study: 29396633

Group type: EXPERIMENTAL
Intervention: ACCEPT intervention
Number of subjects: 103

Group type: COMPARATOR
Intervention: HEALTH control condition
Number of subjects: 103
Study: 27384042

Group type: EXPERIMENTAL
Intervention: LEDT (photobiomodulation therapy using cluster light‐emitting diodes; 104 diodes; wavelength 660 and 850 nm; energy density 1.5 and 4.5 J/cm2; energy 60 J at each point; total energy delivered 600 J)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo irradiation
Number of subjects: 15
Study: 25139338

Group type: EXPERIMENTAL
Intervention: Current smokers
Number of subjects: 6240

Group type: EXPERIMENTAL
Intervention: Current smokers with BMI ≤ 25 kg/m(2)
Number of subjects: 6240

Group type: EXPERIMENTAL
Intervention: Former smokers
Number of subjects: 6240

Group type: EXPERIMENTAL
Intervention: All smokers (current and former)
Number of subjects: 6240

Group type: COMPARATOR
Intervention: Smokers
Number of subjects: 6240
Study: 23131207

Group type: EXPERIMENTAL
Intervention: 10 μg dose of hemagglutinin (HA) antigen
Number of subjects: 380

Group type: EXPERIMENTAL
Intervention: 15 μg dose of hemagglutinin (HA) antigen
Number of subjects: 380

Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 380
Study: 16020626

Group type: EXPERIMENTAL
Intervention: Small group intervention (educational content on diabetes self-management and discussion of attitudes, feelings, and motivations)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Diabetes self-care book (control group)
Number of subjects: 0
Study: 12413434

Group type: EXPERIMENTAL
Intervention: Staphylococcus toxoid (SB) injections (0.1 ml to 1.0 ml weekly for 6 months)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Staphylococcus toxoid (SB) injections
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo (coloured sterile water)
Number of subjects: 100
Study: 10214601

Group type: EXPERIMENTAL
Intervention: 10% povidone-iodine pledget
Number of subjects: 5

Group type: COMPARATOR
Intervention: 10% povidone-iodine swabstick
Number of subjects: 5

Group type: COMPARATOR
Intervention: 10% povidone-iodine gauze pad
Number of subjects: 5
Study: 7824114

Group type: EXPERIMENTAL
Intervention: Transcranial color‐coded real‐time sonography (TCCS) in severely affected PD patients
Number of subjects: 30

Group type: COMPARATOR
Intervention: Transcranial color‐coded real‐time sonography (TCCS) in remaining PD patients and controls
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Correlation of echogenicity with severity and duration of PD
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Increased echogenicity of the substantia nigra
Number of subjects: 30
Study: 1699088

Group type: EXPERIMENTAL
Intervention: Aprotinin treatment during cardiopulmonary bypass
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo treatment during cardiopulmonary bypass
Number of subjects: 0
Study: 113627

Group type: EXPERIMENTAL
Intervention: Primary radiation (Gp R)
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Primary surgery (Gp S)
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Preoperative radiation of 4000 rads in four weeks (Gp R/S)
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Further treatment attempts after initial therapy (Gp R)
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Further treatment attempts after initial therapy (Gp S)
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Further treatment attempts after initial therapy (Gp R/S)
Number of subjects: 55

Group type: COMPARATOR
Intervention: Postoperative complications in primary radiation failures
Number of subjects: 55
Study: 31896121

Group type: EXPERIMENTAL
Intervention: Measurement of plasma ammonia concentration
Number of subjects: 322

Group type: EXPERIMENTAL
Intervention: Protein intake (total and intravenous)
Number of subjects: 322
Study: 29705931

Group type: EXPERIMENTAL
Intervention: Increased in-degree centrality
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Increased betweenness centrality
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Network position
Number of subjects: 0
Study: 29119726

Group type: EXPERIMENTAL
Intervention: Cotrimoxazole (CTX) prophylaxis
Number of subjects: 220

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 220
Study: 25547632

Group type: EXPERIMENTAL
Intervention: Cognitive and motor stimulation interventions (CMSI) administered by a single care provider
Number of subjects: 84

Group type: COMPARATOR
Intervention: Standard support
Number of subjects: 84
Study: 23399084

Group type: EXPERIMENTAL
Intervention: Cyclosporine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Oral dexamethasone pulses plus mycophenolate mofetil
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 21937380

Group type: EXPERIMENTAL
Intervention: Transoral incisionless fundoplication (TIF), n=34
Number of subjects: 52

Group type: COMPARATOR
Intervention: Nissen laparoscopic fundoplication (NLF), n=18
Number of subjects: 52
Study: 18431216

Group type: EXPERIMENTAL
Intervention: Ventriculoperitoneal shunt surgery
Number of subjects: 647
Study: 17179108

Group type: EXPERIMENTAL
Intervention: MSD-SCT
Number of subjects: 191

Group type: COMPARATOR
Intervention: Chemotherapy alone
Number of subjects: 191

Group type: EXPERIMENTAL
Intervention: MUD/MMFD-SCT
Number of subjects: 191
Study: 14604055

Group type: EXPERIMENTAL
Intervention: Mental practice group
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Physical practice group
Number of subjects: 35

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 35
Study: 11076325

Group type: EXPERIMENTAL
Intervention: 4-day antibiotic therapy
Number of subjects: 73

Group type: COMPARATOR
Intervention: 7-day antibiotic therapy
Number of subjects: 73
Study: 9103686

Group type: EXPERIMENTAL
Intervention: Microgynon (combined pill)
Number of subjects: 1076

Group type: EXPERIMENTAL
Intervention: Depo-Provera
Number of subjects: 1076

Group type: EXPERIMENTAL
Intervention: CuT 380A (IUCD)
Number of subjects: 1076
Study: 1568716

Group type: EXPERIMENTAL
Intervention: 3 million units of recombinant interferon‐alpha three times weekly for 12 weeks
Number of subjects: 28

Group type: COMPARATOR
Intervention: No treatment (control)
Number of subjects: 28
Study: 3908782

Group type: EXPERIMENTAL
Intervention: Prostaglandin E1 (PGE1) infusion
Number of subjects: 17

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17
Study: 31941260

Group type: EXPERIMENTAL
Intervention: Terlipressin (1mg intravenous drip or static push every 6-12 hours for more than 5 days)
Number of subjects: 111

Group type: COMPARATOR
Intervention: Conventional treatment (control group)
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: Terlipressin in RA-AKI subgroup
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: Terlipressin in RA-NAKI subgroup
Number of subjects: 111
Study: 29866141

Group type: EXPERIMENTAL
Intervention: Brief cognitive behavioral therapy (CBT)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Adaptations to brief CBT
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Therapeutic relationship and individual patient factors
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Adaptations to EBP delivery
Number of subjects: 18
Study: 27153076

Group type: EXPERIMENTAL
Intervention: Ergonomic intervention (details on dosage and duration not specified)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Ergonomic intervention
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 100
Study: 24258770

Group type: EXPERIMENTAL
Intervention: Seated condition tracing task
Number of subjects: 2

Group type: COMPARATOR
Intervention: Standing condition tracing task
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Transfer from standing to seated condition
Number of subjects: 2

Group type: COMPARATOR
Intervention: Training in standing condition
Number of subjects: 2
Study: 21715139

Group type: EXPERIMENTAL
Intervention: Neuromuscular electrical stimulation (NMES) applied for 13 days (interquartile range, 7‐30 days) on brachial biceps and vastus medialis (quadriceps) of 1 side of the body.
Number of subjects: 16
Study: 20350036

Group type: EXPERIMENTAL
Intervention: Interpersonal Psychotherapy for depressed adolescents (IPT‐A)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Treatment as Usual (TAU)
Number of subjects: 63
Study: 18479353

Group type: COMPARATOR
Intervention: Exercise (resistive exercise every 3 days)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Pamidronate (60 mg intravenously, 2 weeks before bed rest)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Pamidronate (60 mg)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Exercise (resistive exercise)
Number of subjects: 25
Study: 15854173

Group type: EXPERIMENTAL
Intervention: 2.4 g/day of mesalazine
Number of subjects: 156

Group type: COMPARATOR
Intervention: 1.2 g/day of mesalazine
Number of subjects: 156
Study: 12416944

Group type: EXPERIMENTAL
Intervention: Next-day care at the study site's primary care center
Number of subjects: 156

Group type: COMPARATOR
Intervention: Usual same-day care
Number of subjects: 156

Group type: EXPERIMENTAL
Intervention: Next-day care
Number of subjects: 156
Study: 10604820

Group type: EXPERIMENTAL
Intervention: Cotrimoxazole (TMP/SMX) 4 mg/kg TMP/20 mg/kg SMX at two divided doses for 5 days
Number of subjects: 68
Study: 8949315

Group type: EXPERIMENTAL
Intervention: Trandolapril
Number of subjects: 1679

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1679
Study: 1685572

Group type: EXPERIMENTAL
Intervention: Controlled-release remoxipride (REM-CR), 361 mg daily
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Immediate-release remoxipride (REM-IR), 332 mg daily
Number of subjects: 150

Group type: COMPARATOR
Intervention: Haloperidol, 12.5 mg daily
Number of subjects: 150
Study: 7235372

Group type: EXPERIMENTAL
Intervention: 0.5 ppm ozone exposure for 5 consecutive days
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: 0.5 ppm ozone exposure
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Ozone exposure
Number of subjects: 24
Study: 31780765

Group type: EXPERIMENTAL
Intervention: Amfepramone (AFP) 75 mg single dose
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Genetic variants ABCB1‐rs1045642 and CYP3A4‐rs2242480
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: ABCB1 and CYP3A4 gene polymorphisms
Number of subjects: 36
Study: 29158669

Group type: EXPERIMENTAL
Intervention: Senior meetings
Number of subjects: 416

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 416
Study: 26350480

Group type: EXPERIMENTAL
Intervention: Remote ischemic conditioning (RIC)
Number of subjects: 494

Group type: COMPARATOR
Intervention: No intervention (Control)
Number of subjects: 494
Study: 23551037

Group type: EXPERIMENTAL
Intervention: Parent-based intervention with booster during the fall semester
Number of subjects: 1900

Group type: EXPERIMENTAL
Intervention: Parent-based intervention prior to college matriculation
Number of subjects: 1900

Group type: EXPERIMENTAL
Intervention: Parent-based intervention after college matriculation
Number of subjects: 1900
Study: 21823222

Group type: EXPERIMENTAL
Intervention: Very-low-fat diet (VLFD; 11% of energy as fat)
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Step 1 diet supplemented with soy food (SFD; 50 mg isoflavones per day)
Number of subjects: 59

Group type: COMPARATOR
Intervention: Control Step 1 diet (CD; 27% energy as fat) with no SFD
Number of subjects: 59
Study: 19356986

Group type: EXPERIMENTAL
Intervention: Low-magnitude mechanical signals (LMMS) at 30Hz for 10min/day, peak-to-peak acceleration magnitudes of 0.3g (n=12) or 0.5g (n=6)
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Low-magnitude mechanical signals (LMMS)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Control group (CTRs)
Number of subjects: 33
Study: 17410108

Group type: EXPERIMENTAL
Intervention: Carotid stenting
Number of subjects: 7000

Group type: COMPARATOR
Intervention: Carotid endarterectomy
Number of subjects: 7000
Study: 15485438

Group type: EXPERIMENTAL
Intervention: Amiodarone
Number of subjects: 866

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 866
Study: 11528571

Group type: EXPERIMENTAL
Intervention: Acellular pertussis (AP) vaccine
Number of subjects: 199

Group type: COMPARATOR
Intervention: Licensed meningococcal vaccine (MN)
Number of subjects: 199
Study: 9850804

Group type: EXPERIMENTAL
Intervention: Optical-acoustic stimulation (OAS)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Electrical stimulation (ES)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Rest
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo stimulation
Number of subjects: 30
Study: 8031160

Group type: EXPERIMENTAL
Intervention: MTX/5-FU with 5'-DFUR (group A)
Number of subjects: 75

Group type: COMPARATOR
Intervention: MTX/5-FU without 5'-DFUR (group B)
Number of subjects: 75
Study: 2656264

Group type: EXPERIMENTAL
Intervention: Mother present during induction of anaesthesia
Number of subjects: 49

Group type: COMPARATOR
Intervention: No parent present during induction of anaesthesia
Number of subjects: 49
Study: 31140654

Group type: EXPERIMENTAL
Intervention: Day-and-night hybrid closed-loop insulin delivery using Cambridge FlorenceM system
Number of subjects: 20
Study: 30116118

Group type: EXPERIMENTAL
Intervention: Proprioceptive training
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Lower-limb muscular strength training
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 30
Study: 27310328

Group type: EXPERIMENTAL
Intervention: Omeprazole (40 mg once daily)
Number of subjects: 24

Group type: COMPARATOR
Intervention: 2D regimen (ombitasvir/paritaprevir/ritonavir 25/150/100 mg once daily)
Number of subjects: 24

Group type: COMPARATOR
Intervention: 3D regimen (ombitasvir/paritaprevir/ritonavir and dasabuvir 250 mg twice daily)
Number of subjects: 24
Study: 24742978

Group type: EXPERIMENTAL
Intervention: 12-month implementation intervention
Number of subjects: 128

Group type: COMPARATOR
Intervention: Usual care control group
Number of subjects: 128
Study: 22653713

Group type: EXPERIMENTAL
Intervention: 500 mg of calcium (as calcium carbonate)
Number of subjects: 450

Group type: EXPERIMENTAL
Intervention: 250 mg of calcium
Number of subjects: 450

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 450
Study: 20460997

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (0.4, 0.6, and 0.8 ng/ml) as an adjunct to propofol-based TIVA
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (0.6-0.8 ng/ml) as an adjunct to propofol-based TIVA
Number of subjects: 44
Study: 18822980

Group type: EXPERIMENTAL
Intervention: Electroacupuncture (EA) group
Number of subjects: 110

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 110
Study: 15699227

Group type: EXPERIMENTAL
Intervention: Soy protein containing isoflavones
Number of subjects: 23

Group type: COMPARATOR
Intervention: Tablets containing extracted soy isoflavones
Number of subjects: 23
Study: 11318020

Group type: EXPERIMENTAL
Intervention: Consecutive heat exposure (10 consecutive days)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Intermittent heat exposure (10 sessions over 3 weeks)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 14
Study: 8996743

Group type: EXPERIMENTAL
Intervention: 1 g cefotiam + 500 mg metronidazole
Number of subjects: 60

Group type: COMPARATOR
Intervention: 2 g cefotiam + 500 mg metronidazole
Number of subjects: 60

Group type: COMPARATOR
Intervention: 2 g cefotiam
Number of subjects: 60
Study: 8487059

Group type: EXPERIMENTAL
Intervention: Immediate-release morphine (IRM) solution (20 mg/mL)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Sustained-release morphine (SRM) formulation (30 mg)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Both IRM and SRM
Number of subjects: 34
Study: 3122629

Group type: EXPERIMENTAL
Intervention: Intravenous diltiazem
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 2512801

Group type: EXPERIMENTAL
Intervention: Moderate weight gain (4-6 g.kg-1.d-1) - MG group
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Rapid weight gain (12-16 g.kg-1.d-1) - RG group
Number of subjects: 22
Study: 31287736

Group type: EXPERIMENTAL
Intervention: Telemedicine-assisted self-management program
Number of subjects: 115

Group type: COMPARATOR
Intervention: Care as usual
Number of subjects: 115
Study: 29101843

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral and mindfulness-based group sleep intervention (n = 63)
Number of subjects: 123

Group type: COMPARATOR
Intervention: Active control 'study skills' intervention (n = 60)
Number of subjects: 123
Study: 26116326

Group type: EXPERIMENTAL
Intervention: Prone position
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Left lateral position
Number of subjects: 16

Group type: COMPARATOR
Intervention: Right lateral position
Number of subjects: 16

Group type: COMPARATOR
Intervention: Supine position
Number of subjects: 16
Study: 24237916

Group type: EXPERIMENTAL
Intervention: Ask-Advise-Connect (AAC) approach
Number of subjects: 0

Group type: COMPARATOR
Intervention: Ask-Advise-Refer (AAR) approach
Number of subjects: 0
Study: 20936482

Group type: EXPERIMENTAL
Intervention: Optimal glycemic control (HbA1c <7%, n = 6)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Poor glycemic control (HbA1c ≥7%, n = 6)
Number of subjects: 30

Group type: COMPARATOR
Intervention: T1DM subjects
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: All subjects
Number of subjects: 30
Study: 19223278

Group type: EXPERIMENTAL
Intervention: Low dose aerobic exercise (20 min/day)
Number of subjects: 207

Group type: EXPERIMENTAL
Intervention: High dose aerobic exercise (40 min/day)
Number of subjects: 207

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 207
Study: 16704894

Group type: EXPERIMENTAL
Intervention: Holmium laser enucleation of the prostate (HoLEP)
Number of subjects: 61

Group type: COMPARATOR
Intervention: Transurethral resection of the prostate (TURP)
Number of subjects: 61
Study: 14679493

Group type: EXPERIMENTAL
Intervention: Active Cycle of Breathing Techniques (ACBT)
Number of subjects: 10

Group type: COMPARATOR
Intervention: High-Frequency Chest Compressions (HFCC)
Number of subjects: 10
Study: 11311035

Group type: EXPERIMENTAL
Intervention: Modified instruction (verbalizing sorting strategy)
Number of subjects: 73

Group type: COMPARATOR
Intervention: Standard instruction
Number of subjects: 73
Study: 9010986

Group type: EXPERIMENTAL
Intervention: Dolasetron mesilate 1.8 mg/kg
Number of subjects: 226

Group type: EXPERIMENTAL
Intervention: Dolasetron mesilate 1.2 mg/kg
Number of subjects: 226

Group type: COMPARATOR
Intervention: Metoclopramide 7 mg/kg
Number of subjects: 226

Group type: EXPERIMENTAL
Intervention: Dolasetron mesilate
Number of subjects: 226

Group type: COMPARATOR
Intervention: Metoclopramide
Number of subjects: 226
Study: 8054248

Group type: EXPERIMENTAL
Intervention: Ethanol (0.80 g/kg body weight)
Number of subjects: 12
Study: 3396546

Group type: EXPERIMENTAL
Intervention: Halothane anaesthesia
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Isoflurane anaesthesia
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control values
Number of subjects: 20
Study: 31603510

Group type: EXPERIMENTAL
Intervention: Group 1 (headache (+) aura (+))
Number of subjects: 130

Group type: COMPARATOR
Intervention: Group 4 (headache (−) aura (−))
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Group 3 (headache (−) aura (+))
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Group 2 (headache (+) aura (−))
Number of subjects: 130
Study: 31511054

Group type: EXPERIMENTAL
Intervention: Manual acupuncture (MA)
Number of subjects: 86

Group type: COMPARATOR
Intervention: Sham acupuncture (SA)
Number of subjects: 86